No Data
Joinn Laboratories (06127.HK) spent 10.3335 million yuan on January 3 to repurchase 0.6137 million A-shares.
On January 3, 2023, Gelonghui reported that Joinn Laboratories (06127.HK) announced the repurchase of 613,700 A-shares for 10.3335 million yuan, with a repurchase price of 16.35 to 17.2 yuan per share.
Joinn Laboratories(China)Co.,Ltd.'s (SHSE:603127) Share Price Could Signal Some Risk
Joinn Laboratories (06127) spent 3.282 million yuan on December 31 to repurchase 0.194 million A-shares.
Joinn Laboratories (06127) announced that it will spend 3.282 million yuan to buy back ...
Joinn Laboratories (06127.HK) spent 1.704 million yuan to repurchase 0.1 million A-shares on December 30.
On December 30, Gelonghui reported that Joinn Laboratories (06127.HK) announced the repurchase of 0.1 million A-shares, costing 1.704 million yuan, on December 30, 2024, with a repurchase price of 16.88-17.11 yuan per share.
Highly resilient! Leading CRO companies have stabilized their fundamentals, but the shadow of the biosafety bill may still linger next year | Year-end review.
① In 2024, the USA Biodefense Act will disrupt CROs throughout the year and may continue next year; ② In the first three quarters of this year, over half of listed companies experienced revenue growth, and leading CROs demonstrated resilience; ③ Research on popular targets such as ADC, GLP-1, and bispecific antibodies will continue to be hot; ④ In 2025, the performance of leading CROs and small to medium enterprises may further diverge.
Joinn Laboratories (06127.HK) spent 1.714 million yuan to repurchase 0.1 million shares of A-shares on December 23.
On December 23, Gelonghui reported that Joinn Laboratories (06127.HK) announced that on December 23, 2024, it spent 1.714 million yuan to repurchase 0.1 million A-shares, with a repurchase price of 17.1 to 17.18 yuan per share.
Earnings Working Against Joinn Laboratories(China)Co.,Ltd.'s (SHSE:603127) Share Price
Unlock the Full List
